CompletedNCT02146911
Bupropion or Varenicline With Email Support for Smoking Cessation
About this title
Read the official source — NCT02146911Medication studyAges 19–90CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 19 years to 90 years.
- Listed locations
- TorontoSee all locations and recruitment
Study information
Study start dateStarted: May 1, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 968
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Locations
- Canada
- Age range
- From 19 Years to 90 Years
- Official registry ID
- NCT02146911
- Official title
Show the full official title
Evaluating the Real-world Effectiveness of Varenicline and Bupropion for Long-term Smoking Cessation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Bupropion and Varenicline.
Who was this study for?
Listed age limits: 19 years to 90 years.
